What is possible diagnosis of this nail discoloration..
toenail discoloration subungual dark greenish brown discoloration onychomycosis
toenail discoloration differential diagnosis onychomycosis subungual hematoma melanonychia green nail
| Diagnosis | Features Supporting It | Features Against |
|---|---|---|
| Onychomycosis (Tinea unguium) | Dystrophy, thickening, yellowish-white areas, nail plate crumbling, common in toenails | Green tinge less typical without secondary infection |
| Pseudomonas aeruginosa nail infection (Chloronychia / "Green Nail Syndrome") | Greenish-brown/black discoloration under nail, onycholysis, can co-occur with fungal infection | Usually green is more vivid; typically in fingernails but can occur in toes |
| Subungual hematoma | Dark discoloration (blood pooling under nail), trauma history, seen in great toe | Blood usually reddish-purple, not greenish |
| Subungual melanoma | Dark pigmentation under nail, nail dystrophy | No visible longitudinal melanonychia band; Hutchinson's sign not visible |
⚠️ This is for educational purposes only. A formal diagnosis requires in-person clinical examination, history, and laboratory confirmation by a qualified clinician.
Probable treatment
onychomycosis treatment antifungal terbinafine itraconazole topical systemic
green nail syndrome Pseudomonas chloronychia treatment antibiotics topical
onychomycosis terbinafine itraconazole pulse therapy duration cure rate toenail
Pseudomonas nail infection topical ciprofloxacin acetic acid treatment management
| Approach | Details |
|---|---|
| Trim/debride the nail | Remove as much of the separated, dystrophic nail plate as possible to eliminate the moist subungual environment |
| Topical acetic acid soaks | 1–2% acetic acid (dilute white vinegar) soaks for 10–15 min twice daily — directly bactericidal against Pseudomonas |
| Topical ciprofloxacin/gentamicin ear/eye drops | Applied under the lifted nail edge twice daily; highly effective for localized Pseudomonas nail infections |
| Oral ciprofloxacin | 500–750 mg twice daily × 2–3 weeks if infection is extensive or non-responsive to topical treatment |
| Keep nail dry | Moisture perpetuates Pseudomonas colonization — avoid prolonged wet exposure |
Per Harrison's Principles of Internal Medicine (p. 4840): the green discoloration in green nail syndrome results from pyocyanin diffusion into the nail bed from P. aeruginosa.
| Drug | Regimen | Duration | Notes |
|---|---|---|---|
| Terbinafine (preferred) | 250 mg/day orally | 12 weeks for toenail | Highest mycological cure rates (~70–80%); fungicidal |
| Itraconazole | 200 mg/day continuously × 12 weeks OR pulse: 400 mg/day × 1 week/month × 3–4 months | 12 weeks or 3–4 pulse cycles | Fungistatic; check drug interactions |
Per Harrison's (p. 6315): "Itraconazole and terbinafine both accumulate in the nail plate" — this is why shorter courses can have prolonged effects.
| Drug | Regimen | Notes |
|---|---|---|
| Efinaconazole 10% solution | Apply to affected nail daily × 48 weeks | Evidence-based per Harrison's; best penetration of topicals |
| Ciclopirox 8% nail lacquer | Apply daily, remove weekly × 48 weeks | Less effective for toenail alone; useful as adjunct |
| Tavaborole 5% solution | Apply daily × 48 weeks | Newer agent with good nail penetration |
| Timepoint | Action |
|---|---|
| Baseline | LFTs before starting oral terbinafine/itraconazole (hepatotoxicity risk) |
| 6 weeks | Clinical response check; repeat LFTs if symptomatic |
| 3 months | Assess mycological cure (repeat KOH/culture) |
| 12–18 months | Full nail regrowth expected — final cosmetic assessment |
⚠️ This information is for educational purposes. Treatment should be individualized by a qualified clinician after culture confirmation and assessment of contraindications (e.g., hepatic disease, drug interactions).